Form 4 for VRTX Vertex Pharmaceuticals
Accepted 2023-05-04 00:00:00 ET · period of report 2023-05-02 · accession 0001209191-23-027372 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| M | 2023-05-04 | 2023-05-02+ | VRTX | LEIDEN JEFFREY M | Executive COB, Dir | S - Sale | $349.98 | -11.0K | 37.4K | -23% | -$3.84M |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2023-05-02 | S | D | 4,645 | $349.48 | 43,704 | D | — | — | (F2) Dr. Leiden undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price. (F3) Open market sales reported on this line occurred at a weighted average price of $349.48 (range $349.00 to $349.99). |
| 2 | Common | Common Stock | 2023-05-02 | S | D | 1,505 | $350.48 | 42,199 | D | — | — | (F2) Dr. Leiden undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price. (F4) Open market sales reported on this line occurred at a weighted average price of $350.48 (range $350.08 to $351.01). |
| 3 | Common | Common Stock | 2023-05-02 | S | D | 300 | $353.18 | 41,899 | D | — | — | (F2) Dr. Leiden undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price. (F5) Open market sales reported on this line occurred at a weighted average price of $353.18 (range $352.63 to $353.53). |
| 4 | Common | Common Stock | 2023-05-03 | S | D | 2,008 | $349.22 | 39,891 | D | — | — | (F2) Dr. Leiden undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price. (F6) Open market sales reported on this line occurred at a weighted average price of $349.22 (range $349.00 to $349.94). |
| 5 | Common | Common Stock | 2023-05-03 | S | D | 1,800 | $350.53 | 38,091 | D | — | — | (F2) Dr. Leiden undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price. (F7) Open market sales reported on this line occurred at a weighted average price of $350.53 (range $350.08 to $350.90). |
| 6 | Common | Common Stock | 2023-05-03 | S | D | 700 | $351.59 | 37,391 | D | — | — | (F2) Dr. Leiden undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price. (F8) Open market sales reported on this line occurred at a weighted average price of $351.59 (range $351.33 to $352.02). |